Navigation Links
Suven Seeks Permission for Trials of New Drug

Hyderabad, July 12 (IANS) Suven Life Sciences has submitted an application with the Drug Controller General of India for permission to undertake phase-1 clinical trials of its new drug Suvn-502 for treatment of cognitive disorders such as Alzheimer's and schizophrenia.

'Treatment for Alzheimer's disease and Schizophrenia is an unmet medical need and Suven's primary focus is to discover drugs that address significant unmet medical needs,' said a statement by the firm.

Suven is a Hyderabad-based life sciences company, which is involved in contract research and manufacturing services, drug discovery and development support services and collaborative research partner with global pharma majors.

Suven's research focuses on developing treatments for Central Nervous System (CNS) disorders through novel mechanisms using small-molecule medicinal chemistry approaches.


'"/>




Page: 1

Related medicine news :

1. Gujarat Seeks To Scale Down Infant Mortality Rate
2. Europe Seeks Indian Expertise
3. Book Seeks To Rehabilitate Soldiers
4. Government Seeks To Wipe Out Prostitution
5. Multiple Sclerosis Patient Seeks Help of Stem Cells
6. AIIMS Doctors Seeks Ramadoss Intervention For Venugopal’s Remova
7. Human Chain Seeks AIIMS Status For Tiruchi Medical College
8. Harney Seeks Approval for New Medical Practitioners Bill
9. Drug Company Seeks Approval for Human Testing of Vaccine against H5N1 Virus
10. BJP Seeks Tougher Laws Against Pre-Natal Sex Tests
11. Valiathan Committee Seeks Documents from AIIMS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... London, Ontario (PRWEB) , ... May 31, 2016 , ... ... more than 2,000 clients already know – London is home to Ontario’s leading day ... and direction of visionary Fayez Tamba began with a unique concept to combine spa ...
(Date:5/31/2016)... ... , ... In his latest video, renowned AstroNumerologist Jesse Kalsi ... presidential candidate Donald Trump as an example, Kalsi describes the way AstroNumerology conveys ... adding numbers up,” says Kalsi. “It is about looking at each individual number, ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Interest is on ... screening tool and as an orthogonal tool for RNAi hit validation. A key reason ... specific guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed formats. ...
(Date:5/31/2016)... ... ... In a recent interview on The Greenburgh Report radio show hosted by Greenburgh, NY ... AM), leading medical insurance advocate Adria Goldman Gross discussed several eye-opening issues that have ... During the interview with Mr. Feiner that aired on May 7, 2016, Ms. Gross, ...
(Date:5/31/2016)... Chicago, IL (PRWEB) , ... May 31, 2016 ... ... industry-leading multichannel marketing services firm and statement solutions provider, for the ... released in the May 2016 issue of Advertising Age, and SourceLink ranked eighteenth ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)...   Plexus Technology Group, LLC (Plexus ... systems (AIMS), is pleased to announce the addition ... of Technology. In this new capacity, Mr. Marcey ... company,s technological development. He will collaborate with each ... expansion of new products, product features and enhancements.  ...
(Date:5/31/2016)... York , May 31, 2016 ... essential ingredient in food, cosmetics and pharmaceuticals, with global ... revenues worth US$ 1.6 Bn. Demand for ... products, juices, and yogurts will continue its upward momentum ... trend will also boost positive sentiment on aloe vera, ...
(Date:5/31/2016)... Israel , May 31, 2016 ... its proprietary plant-based rhCollagen technology for tissue repair products ... Chief Scientist of Israel,s Ministry ... 12 million development project for 2016. The Chief Scientist,s grant ... year,s authorized grant, which totaled NIS 4.7 million.  ...
Breaking Medicine Technology: